Short answer
ASP Isotopes Inc. (ASPI) filed an 8-K current report with the SEC on October 2, 2026 reporting Item 7.01 (Regulation FD Disclosure). ENDRA filed Form S-4 on October 2, 2026, advancing the proposed merger involving ASPI’s Renergen and Noble Africa subsidiaries.
ASP Isotopes Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- ENDRA filed Form S-4 on October 2, 2026, advancing the proposed merger involving ASPI’s Renergen and Noble Africa subsidiaries
- Merger remains conditional on ENDRA stockholder approval, financing completion, regulatory clearances and other closing conditions
- Investor focus: funding risk for Renergen’s Virginia Gas Project, including expected U.S. DFC or Standard Bank SA financing
- Combined company’s Nasdaq listing and post-closing cash runway remain key unresolved execution risks
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ASP Isotopes Inc. 8-K filings
Get the next ASPI 8-K as it lands
Follow ASPI for push alerts, or ask the research agent what this filing means.